Literature DB >> 9215648

Cytomegalovirus and simian immunodeficiency virus coinfection: longitudinal study of antibody responses and disease progression.

S Baroncelli1, P A Barry, J P Capitanio, N W Lerche, M Otsyula, S P Mendoza.   

Abstract

Antibody titers to rhesus cytomegalovirus (RhCMV) were prospectively analyzed over a period of 68 weeks in a longitudinal serosurvey of 17 RhCMV-seropositive rhesus macaques (Macaca mulatta) experimentally coinfected with simian immunodeficiency virus (SIV). These were compared with anti-RhCMV titers in 18 animals that were also naturally infected with RhCMV but not infected with SIV. Fluctuations in anti-RhCMV antibody titers were observed within 5 weeks of SIV inoculation, and two distinct patterns of RhCMV antibody response were observed in SIV-infected animals. Animals showing a progressive decline in anti-RhCMV immunoglobulin G (IgG) exhibited the most rapid disease progression, coincident with low anti-SIV and anti-tetanus toxoid IgG responses, high levels of p27 antigen in the plasma, and short survival. Animals exhibiting a more stable CMV-specific response after SIV inoculation had the least rapid disease course. Anti-RhCMV antibody titers in SIV-uninfected animals remained relatively stable during the period of study. Evidence that preinoculation immunologic measures predicted postinoculation outcome was equivocal.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215648     DOI: 10.1097/00042560-199705010-00002

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  6 in total

1.  Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.

Authors:  Yujuan Yue; Amitinder Kaur; Meghan K Eberhardt; Nadine Kassis; Shan Shan Zhou; Alice F Tarantal; Peter A Barry
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

2.  Pathogenesis of experimental rhesus cytomegalovirus infection.

Authors:  K M Lockridge; G Sequar; S S Zhou; Y Yue; C P Mandell; P A Barry
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

3.  Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92.

Authors:  Basel T Assaf; Keith G Mansfield; Lisa Strelow; Susan V Westmoreland; Peter A Barry; Amitinder Kaur
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

4.  Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques.

Authors:  Yujuan Yue; Zhongde Wang; Kristina Abel; Jinliang Li; Lisa Strelow; Angelo Mandarino; Meghan K Eberhardt; Kimberli A Schmidt; Don J Diamond; Peter A Barry
Journal:  Med Microbiol Immunol       Date:  2008-01-15       Impact factor: 3.402

5.  Cytomegaloviral hypophysitis in a simian immunodeficiency virus-infected rhesus macaque (Macacca mulatta).

Authors:  Melissa R Berg; Michael A Owston; Marie-Claire Gauduin; Basel T Assaf; Anne D Lewis; Edward J Dick
Journal:  J Med Primatol       Date:  2017-07-03       Impact factor: 0.667

6.  Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.

Authors:  Suresh B Boppana; William J Britt
Journal:  Methods Mol Biol       Date:  2021
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.